Advancing Biomarkers R&D

Experience groundbreaking in-person events, engaging online activities, and cutting-edge digital services that unite influential and passionate leaders with scientific experts, collectively shaping the future of biomarkers and precision medicine.

In-Person & Online Events

Collaborate & Partner for a Better Future

Explore Biomarkers & Precision Medicine

Unite with the biomarkers and precision medicine industry and healthcare sectors with thought leaders across the UK, EU, and USA with our leading Biomarkers & Precision Medicine UK & US as well as Biomarkers & Precision Oncology EU congresses. Immerse yourself in cutting-edge scientific content – from online Monthly Science Exchanges, best practice e-symposiums to eBooks and landscape reports offering unparalleled opportunities in biomarkers innovation across the value chain of discovery, translation and clinical development. 

Resources & Announcements

13/05/24 - A test that identifies Zika distinct from dengue could make a definite impact to expectant mothers and reproductive-age women that are at risk from the mosquito-borne disease.
18/04/24 - A blood test for the phosphorylated protein pTau-217 could be a critical step towards early diagnosis and screening of Alzheimer's disease.
10/04/24 - Detecting the aggregation of TDP-43 spells a new diagnostic tool for MND.
21/03/24 - Biomarker discovery in medical research traditionally relied on controlled trials. Now, Real-World Data Analytics offers a transformative approach, analyzing real-world patient data to identify new biomarkers and improve patient care.
14/03/24 - Aural Analysis's Speech Vitals and Linus Health's expansion into linguistic analysis herald a promising era in early detection and treatment.
22/02/24 - Biomarkers by Oxford Global will explore the essential criteria for validating clinical biomarkers, shedding light on the steps and challenges involved.

Online Activities

06/06/24, 15:00 | Science Exchange

How Translational Research Can Impact the Development of Precision Medicine

Presented by Mohamed Hassanein, Director, Translational Medicine at Pfizer
23/07/24 | Science Exchange

The Application Of Multiplex Technologies In Biomarker Development

02/09/24 | Science Exchange

Regulatory developments for biomarker research

01/10/24 | Science Exchange

Multi- Omics Approaches To Biomarker Discovery

Oxford Global PLUS Pass

Introducing the PLUS Pass – your exclusive 12-month, all-access gateway to over 40 prestigious events hosted annually across the UK, Europe, and the US.

Tailored for experts, thought-leaders, and scientists from global pharma & biotech, the PLUS Pass not only grants you entry to our curated event experiences but also offers boundless knowledge sharing through our robust PLUS Platform. Immerse yourself in a wealth of on-demand event recordings, content articles, and industry news, while engaging in thought-provoking exclusive webinars and stimulating group discussions each month.

Oxford Global PLUS


Driving impact, awareness, and business generation

Our extensive and engaged community extends across large, mid-size and innovative start-ups within the pharma and biotech space, with a dedicated audience spanning a range of specialisms. Whether you have content to share, are looking for ways to enhance your brand visibility or would like to increase engagement with prospective customers, Oxford Global can offer valuable access to your target demographic through our range of event & content services.

Subscribe to Our Newsletter

Sign up for our monthly newsletter to
keep up with all things biomarkers